Shandong Sanyuan Biotechnology (301206.SZ) has issued a profit forecast, with an expected annual net profit of 95 million to 120 million yuan, a year-on-year increase of 61.36% to 103.82%.
San Yuan Biological (301206.SZ) disclosed its performance forecast for the year 2024, and the company expects that the net profit attributable to the shareholders of the listed company...
Shandong Sanyuan Biotechnology (301206.SZ) disclosed its performance forecast for 2024, with the company expecting a net profit attributable to shareholders of the listed company of 95 million to 120 million yuan, an increase of 61.36% to 103.82% year-on-year; the net profit after deducting non-recurring gains and losses is expected to be 92.85 million to 118 million yuan, an increase of 60.97% to 104.31% year-on-year.
Related Articles

Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


